Jiangsu Aoyang Health Industry Co. ltd. Class A

Jiangsu Aoyang Health Industry Co. ltd. Class A

SSZSE:002172
4.25
CNY
-0.32
(-7.00%)
0.05EPS
51.79P/E
2.16BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
6.27
7.15
5.61
7.15
7.35
4.55
3.86
3.96
3.91
2.63
2.63
2.48
2.19
2.44
Basic EPS, GAAP
0.04
-0.11
0.2
0.38
0.21
0.01
-0.55
-0.59
-1.34
-0.02
0.06
0.05
0.05
0.05
Free Cash Flow per Basic Share
0.2
0.49
0.27
0.59
-0.85
-1.25
-1.14
-0.07
-0.33
-0.3
-0.01
-0.03
-0.02
- -
Dividend per Share
0.17
0.18
0.14
0.09
0.09
0.09
0.24
0.15
0.14
0.06
0.04
0.04
0.03
0.04
Book Value per Share
1.13
1.19
1.47
1.62
2.04
2.41
1.82
1.23
0.08
0.06
0.12
0.18
0.23
0.26
Tangible Book Value per Share
0.95
0.84
1.17
1.37
1.73
2.11
1.56
1
-0.02
-0.05
0.02
0.08
0.14
0.17
Basic Weighted Avg Shares
523
654
679
682
731
1,036
773
778
775
768
828
811
826
705
Sales/Revenue/Turnover
3,277
4,676
3,809
4,876
5,372
4,711
2,982
3,083
3,029
2,021
2,174
2,010
1,807
1,720
Operating Margin (%)
4.1
0.95
4.92
6.08
3.96
-0.12
-10.81
-9.39
-4.82
3.67
4.3
5.14
6.32
6.37
Depreciation Expense
201
244
258
252
252
240
232
306
221
76
72
67
62
- -
Net Income, GAAP
21
-72
136
259
154
10
-425
-459
-1,039
-15
50
41
41
38
Effective Tax Rate (%)
- -
- -
8.31
7.23
11.88
- -
- -
- -
- -
- -
28.14
36.72
29.84
32
Profit Margin (%)
0.64
-1.54
3.57
5.32
2.86
0.22
-14.26
-14.89
-34.3
-0.76
2.29
2.02
2.29
2.23
Working Capital
-852
-1,379
-1,056
-804
-1,063
-1,128
-1,666
-1,847
-676
-692
-726
-598
-602
-585
LT Debt
- -
90
60
30
30
722
755
605
161
101
108
106
67
64
Total Equity
835
858
1,180
1,337
1,691
2,023
1,442
968
51
27
75
115
157
181
Return on Invested Capital (%)
- -
- -
2.63
9.48
4.71
- -
- -
- -
- -
- -
4.4
3.81
4.65
4
Return on Capital (%)
- -
- -
10.2
12.54
7.01
- -
- -
- -
- -
- -
5.85
5.59
6.04
5.42
Return on Common Equity (%)
3.41
-11.02
16.11
23.47
11.43
0.62
-25.93
-38.84
-204.61
-28.63
71.96
35.52
26.6
21.75

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
788
741
868
LT Borrowings
67
67
63
LT Finance Leases
- -
- -
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
766
766
766
Market Capitalization
3,040
3,101
2,159

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
935
894
954
Cash, Cash Equivalents & STI
406
314
418
Accounts Receivable, Net
294
314
304
Inventories
133
130
123
Total Current Liabilities
1,537
1,505
1,539
Payables & Accruals
- -
- -
- -
ST Debt
788
741
868
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12.55%
25.54%
36.54%
Free Cash Flow
30.54%
91.62%
-29.22%
Net Income, GAAP
-465.14%
-82.41%
1.8%
Sales/Revenue/Turnover
-5.26%
-9.03%
-10.1%
Total Cash Common Dividend
-3.34%
-22.11%
-12.77%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
582
450
470
508
2,010
2025
452
451
- -
446
1,807
2026
407
416
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.04
0.01
- -
- -
0.05
2025
0.02
0.02
- -
- -
0.05
2026
0.01
0.02
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.01
0.01
0.01
0.04
2025
0.01
0.01
- -
0.01
0.03
2026
0.02
0.01
- -
- -
- -

Company Description

CEO
Jing Li
Full Time Employees
2,012
Sector
Process industries
Industry
Textiles
Address
No. 18, Tangshi Town Middle Road Zhangjiagang JS China 215618
IPO Date
Sep 24, 2007
Website
ayjk.cn
Business
Jiangsu Aoyang Health Industry Co., Ltd. (002172.SZ) manufactures and sells chemical fibers while engaging in health industry investments, including medical services, pharmaceutical distribution, and health management; its core products and services encompass viscose staple fibers, viscose fiber products, degradable fibers, functional fibers, textile raw materials, textiles, chemical products, steam heat supply, power production, pharmaceutical logistics, health management services, and medical treatments such as hyperbaric oxygen therapy. The company operates primarily in China through segments including chemical fibers, medical logistics, medical services featuring investments in hospitals and research centers, and health management via healthcare centers. Founded in 2001 and headquartered in Zhangjiagang, Jiangsu Province, it changed its name from Jiangsu Aoyang Technology Corporation Limited in September 2018 and listed on the Shenzhen Stock Exchange in 2007 as a subsidiary of Aoyang Group. Recent developments include a September 2025 share transfer agreement for Zhangjiagang Yuesheng Technology Partnership to acquire a 20% stake from Aoyang Group for approximately CNY 590 million, a planned 35 million yuan investment in the Jiangsu Aoyang Hospital for Geriatrics project with 105 beds via subsidiary Zhangjiagang Aoyang Geriatrics Hospital, a 17 million yuan capital injection into subsidiary Aoyang Nursing Home in August 2025, and property lease renewals for nursing operations.